DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
High K, George LA, Eyster ME. , et al.
A phase 1/2 trial of investigational SPK-8011 in hemophilia A demonstrates durable expression and prevention of bleeds.
Blood 2018;
132: 487
We do not assume any responsibility for the contents of the web pages of other providers.